(2023). Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom. Age Ageing, 52. http://doi.org/10.1093/ageing/afad177
. drug safety
(2022). Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records. Lancet Reg Health Eur, 22, 100489. http://doi.org/10.1016/j.lanepe.2022.100489
. (2022). Non-steroidal anti-inflammatory drugs and risk of myocardial infarction adjusting for use of proton pump-inhibitors in patients with no major risk factors: a nested case-control study in the UK Clinical Practice Research Datalink. Eur Heart J Cardiovasc Pharmacother. http://doi.org/10.1093/ehjcvp/pvac041
. (2021). Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study. Can J Diabetes. http://doi.org/10.1016/j.jcjd.2021.12.005
.